Edesa Biotech: CEO Nijhawan Pardeep received 6,893 shares

What happened

• Nijhawan Pardeep, CEO, received 6,893 restricted share units (transaction code A) on Oct 5, 2026. The filing shows an acquisition price of $0.00, total $0.
• Footnote F1 states the grant was pursuant to the issuer's 2019 Equity Incentive Compensation Plan and vested in full upon grant.

Key details

• Transaction date and price: Oct 5, 2026; $0.00 per share; total $0.
• Reported on Form 4 filed Oct 6, 2026. The filing does not indicate a late filing.
• Shares owned after the transaction: not stated in the provided filing.
• Footnotes:
  • F1: grant of restricted share units that vested in full upon grant under the 2019 Equity Incentive Compensation Plan.
  • F2: several entities are wholly owned by the reporting person; he disclaims beneficial ownership except to the extent of his pecuniary interest.
  • F3: reporting person is a co-trustee of The New Nijhawan Family Trust 2015 and disclaims beneficial ownership except to the extent of his pecuniary interest.

Why it may matter

• The filing reports an award of restricted share units that vested in full upon grant (not a market purchase or sale).
• The filing does not show why the insider traded or why the company acted.